Cancer Home > I-131 and Bexxar

A healthcare provider may prescribe Bexxar® (tositumomab) to treat certain types of non-Hodgkin's lymphoma, a cancer that begins in the lymphatic system. Bexxar is a synthetic (manufactured) monoclonal antibody.
 
As part of the treatment regimen, Bexxar is linked to a radioactive element (Iodine I-131). Radioactive treatment such as this is sometimes called radioimmunotherapy.
 
Bexxar binds to the surface of healthy and certain cancerous cells, signaling the immune system to destroy the cancer cells. In addition, because Bexxar is linked to I-131, it emits radiation that helps destroy both the cancer cell the medicine is attached to and surrounding cancer cells.
 
(Click Bexxar for more details on how this drug works to help destroy cancer cells. This article also discusses possible side effects, dosing guidelines, and safety precautions.)
Written by/reviewed by:
Last reviewed by: Kristi Monson, PharmD;
Last updated/reviewed:
List of references (click here):
Advertisement
Topics

Medications

Quicklinks

Related Channels

eMedTV Links
Copyright © 2006-2019 Clinaero, Inc.

eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.

This site complies with the HONcode standard for trustworthy health information:
verify here.